Doberstein Stephen K 4
4 · Dicerna Pharmaceuticals Inc · Filed Mar 16, 2020
Insider Transaction Report
Form 4
Doberstein Stephen K
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2020-03-12+25,000→ 25,000 totalExercise: $15.61Exp: 2030-03-11→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]This option vests as to one-third of the underlying shares on the one year anniversary of the vesting start date of February 4, 2020 and as to the remaining two-thirds of the shares in eight quarterly installments thereafter, subject in each case to the Reporting Person's continued service on the board of directors of the Issuer through each applicable vesting date.